A flurry of acquisitions, mergers and different hashish sector offers adopted President Donald Trump’s Dec. 18 government order instructing marijuana’s standing underneath federal regulation to be downgraded.
However whereas some observers agree that this historic step – and with it, the promise of different main reforms – seems to have been the figuring out issue pushing no less than a few of these offers throughout the end line, hashish M&A stands to be reworked when marijuana rescheduling is finalized, analysts contacted for this text advised MJBizDaily.
“The signed offers we’re seeing are offers which have been labored on for a while now, and the signing of the EO was the catalyst to shut these offers,” mentioned Avis Bulbulyan, CEO of California-based hashish consultancy Siva.
“Over the subsequent couple of months, we’re going to see offers closing the place the signing of the EO was the catalyst to start out taking a look at offers.”
Within the meantime, firms are nonetheless constrained by restricted entry to capital, regulatory uncertainty and a aggressive market whereas trying to place themselves for long-term development.
And that’s whereas they watch for federal officers to finish shifting hashish from Schedule 1 to Schedule 3 of the Managed Substances Act – a doubtlessly revolutionary shift that has no definitive timeline.
“Rescheduling will kick up the M&A exercise, however the dynamics of how that’s going to occur could imply it’s going to take a while,” added Frank Colombo, a managing director at New York-headquartered funding banking and information agency Viridian Capital Advisors.
Trump marijuana rescheduling triggered hashish offers
The primary affect of Trump’s marijuana rescheduling government order was felt when the ink was nonetheless drying.
That day, Curaleaf Holdings noticed its formidable $110 million enlargement into Virginia unravel when it was outbid by $20 million by a Boston-based hedge fund.
Millstreet’s swooping in on the eleventh hour is a probable direct results of Trump’s government order, Bulbuyan mentioned, including that Curaleaf was more likely to have closed on the deal and entered Virginia had Trump not signed the EO.
“Earlier than the precise signing of the manager order, the writing on the wall was there, and a number of firms began to place themselves as an acquirer or goal,” he mentioned.
“The chief order introduced a clearer understanding of the place issues are headed, which is giving stakeholders confidence and as a lot stability as one can count on in a extremely unstable market.”
Different transactions introduced within the days and weeks after the manager order embody:
- Minneapolis-based marijuana multistate operator Vireo Development’s buy of Eaze, the onetime “Uber of Weed,” introduced Dec. 22
- Oregon edibles-maker Wyld’s acquisition of competitor Grön, introduced Jan. 5
- Logistics agency Nabis’ acquisition of Humble Hashish Options, introduced Jan. 6
- California edible and vape model Sunderstorm’s buy of pre-roll model Lime, introduced Jan. 12
- KEY Funding Companions’ acquisition of Denver-based MSO BellRock Manufacturers, whose portfolio consists of Mary’s Medicinals and Dixie Elixirs, introduced Jan. 12
Within the latter case, former Curaleaf CEO Joe Bayern would be the CEO of the newly shaped MM Manufacturers.
In a press release, KEY Funding founding companion Jordan Youkilis famous that “hashish rescheduling on the horizon” made the transfer “the right deal on the excellent time.”
Hashish firms not ready for marijuana rescheduling to search out alternatives
Wyld’s deal to purchase Grön was within the works for months regardless of a stagnant M&A panorama attributed to restricted entry to capital, mentioned Grön President Draper Bender.
“The hope is that as rescheduling progresses, there’s renewed optimism that each fairness and debt capital markets will start to reopen for the sector,” he mentioned.
“With entry to capital, these operators can pursue extremely complementary acquisitions the place near-term synergies throughout manufacturing, distribution, branding and overhead may be realized throughout the first yr.”
However as observers identified, some hashish operators weren’t ready on rescheduling to start out making strikes.
Vireo’s October acquisitions of Schwazze and PharmaCann continued a shopping for spree that started when it obtained $75 million in fairness financing in December 2024 to amass 4 single-state operators: Deep Roots Harvest in Nevada; The Flowery in Florida; Correct Manufacturers in Missouri; and WholesomeCo Hashish in Utah.
Vireo didn’t reply to a request for remark, however in response to Colombo, the corporate is giving itself time to recalibrate its new purchases with out the burden of heavy debt by buying struggling companies at low valuations and paying with inventory.
How Trump marijuana rescheduling may remodel hashish M&A eternally
As 2026 progresses, the trade is watching exercise in Washington, with the hope that finalized hashish rescheduling will loosen up capital for extra M&A exercise – and, finally, an entire new class of offers.
“Many of the M&A of the previous expanded on the infrastructure facet of the trade,” Bulbulyan mentioned.
“Transferring ahead, you’re going to see much less infrastructure offers and extra tasks the place enterprise and income fashions, IP and present infrastructure is introduced collectively in significant methods.”
Margaret Jackson may be reached at margaret.jackson@mjbizdaily.com.
